ENTA ENANTA PHARMACEUTICALS INC
Nasdaq · SEC CIK 1177648 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $183.2K 9 sales by 7 insiders
- Filings on record
- 177 since 2021-08-23, latest 2026-08-10 09:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| Or Yat Sun | CSO | — | $34.0K |
| Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| Luu Brendan | Chief Business Off | — | $19.8K |
| Trout Harry R. III | See Remarks | — | $13.0K |
| Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| Capps Kathleen S. | See Remarks | — | $7,486 |
| Kowalsky Matthew Paul | CLO | — | — |
Transactions 173
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-15 | 2023-02-13 | ENTA | MELLETT PAUL J | CFO, Treas | A - Grant | $0.00 | +21.0K | 104.5K | +25% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | MELLETT PAUL J | CFO, Treas | F - Tax | $52.77 | -6,904 | 97.6K | -7% | -$364.3K | |
| M | 2023-02-15 | 2023-02-13 | ENTA | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +21.0K | 68.3K | +44% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | Gardiner Nathaniel S. | SVP, GC | F - Tax | $52.77 | -6,735 | 73.3K | -8% | -$355.4K | |
| 2023-02-15 | 2023-02-13 | ENTA | Luu Brendan | SVP, Business Dev | F - Tax | $52.77 | -6,416 | 39.6K | -14% | -$338.6K | |
| M | 2023-02-15 | 2023-02-13 | ENTA | Luu Brendan | SVP, Business Dev | A - Grant | $0.00 | +20.3K | 46.0K | +79% | $0 |
| M | 2023-02-15 | 2023-02-13 | ENTA | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +23.3K | 369.4K | +7% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | Or Yat Sun | SVP, CSO | F - Tax | $52.77 | -7,752 | 374.7K | -2% | -$409.1K | |
| M | 2023-02-15 | 2023-02-13 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | A - Grant | $0.00 | +21.0K | 46.9K | +81% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | F - Tax | $52.77 | -6,725 | 40.1K | -14% | -$354.9K | |
| M | 2023-02-13 | 2023-02-09 | ENTA | MELLETT PAUL J | CFO, Treas | S - Sale | $53.76 | -5,000 | 84.3K | -6% | -$268.8K |
| D | 2023-01-10 | 2023-01-09 | ENTA | MELLETT PAUL J | CFO, Treas | M - OptEx | $14.18 | +2,812 | 88.5K | +3% | +$39.9K |
| D | 2022-12-19 | 2022-12-19 | ENTA | Luly Jay R. | Pres, CEO, Dir | M - OptEx | $27.58 | +14.5K | 788.3K | +2% | +$399.9K |
| D | 2022-12-19 | 2022-12-19 | ENTA | MELLETT PAUL J | CFO, Treas | M - OptEx | $14.18 | +4,148 | 85.7K | +5% | +$58.8K |
| DM | 2022-12-16 | 2022-12-16 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale+OE | $44.72 | -30.0K | 773.8K | -4% | -$1.34M |
| DM | 2022-12-16 | 2022-12-16 | ENTA | Luly Jay R. | Pres, CEO, Dir | M - OptEx | $14.10 | +30.0K | 790.0K | +4% | +$422.9K |
| 2022-12-05 | 2022-12-01 | ENTA | Gardiner Nathaniel S. | SVP, GC | F - Tax | $44.33 | -1,055 | 59.1K | -2% | -$46.8K | |
| 2022-12-05 | 2022-12-01 | ENTA | Luu Brendan | SVP, Business Dev | F - Tax | $44.33 | -498 | 25.7K | -2% | -$22.1K | |
| 2022-12-05 | 2022-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $44.33 | -5,659 | 773.8K | -0.7% | -$250.9K | |
| 2022-12-05 | 2022-12-01 | ENTA | Or Yat Sun | SVP, CSO | F - Tax | $44.33 | -1,055 | 359.2K | -0.3% | -$46.8K | |
| 2022-12-05 | 2022-12-01 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | F - Tax | $44.33 | -498 | 25.9K | -2% | -$22.1K | |
| 2022-12-05 | 2022-12-01 | ENTA | MELLETT PAUL J | CFO, Treas | F - Tax | $44.33 | -1,055 | 81.5K | -1% | -$46.8K | |
| D | 2022-11-28 | 2022-11-23 | ENTA | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +21.0K | 60.1K | +54% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +7,000 | 27.0K | +35% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +63.0K | 779.5K | +9% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | Luu Brendan | SVP, Business Dev | A - Grant | $0.00 | +18.5K | 26.2K | +240% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | A - Grant | $0.00 | +18.5K | 26.4K | +235% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | MELLETT PAUL J | CFO, Treas | A - Grant | $0.00 | +21.0K | 82.6K | +34% | $0 |
| D | 2022-11-28 | 2022-11-23 | ENTA | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +21.0K | 360.2K | +6% | $0 |
| D | 2022-08-11 | 2022-08-08 | ENTA | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2022-06-21 | 2022-06-17 | ENTA | MELLETT PAUL J | CFO, Treas | M - OptEx | $11.77 | +3,480 | 61.6K | +6% | +$41.0K |
| DM | 2022-04-05 | 2022-04-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $40.63 | +83.3K | 67.8K | New | +$3.39M |
| DM | 2022-04-05 | 2022-04-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $71.60 | -83.3K | 35.0K | -70% | -$5.97M |
| DM | 2022-03-22 | 2022-03-21 | ENTA | CARTER BRUCE L A | Dir | S - Sale+OE | $67.83 | -6,000 | 0 | -100% | -$407.0K |
| D | 2022-03-22 | 2022-03-21 | ENTA | CARTER BRUCE L A | Dir | M - OptEx | $25.58 | +6,000 | 6,000 | New | +$153.5K |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $43.46 | +36.8K | 47.5K | +346% | +$1.60M |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.20 | -36.8K | 35.0K | -51% | -$2.58M |
| 2022-02-15 | 2022-02-14 | ENTA | Luu Brendan | SVP, Business Dev | F - Tax | $62.49 | -489 | 7,723 | -6% | -$30.6K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | Luu Brendan | SVP, Business Dev | A - Grant | $0.00 | +1,412 | 7,086 | +25% | $0 |
| M | 2022-02-15 | 2022-02-14 | ENTA | Luly Jay R. | Pres, CEO | A - Grant | $0.00 | +8,028 | 712.4K | +1% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | Luly Jay R. | Pres, CEO | F - Tax | $62.49 | -2,355 | 716.5K | -0.3% | -$147.2K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | MELLETT PAUL J | CFO, Treas | A - Grant | $0.00 | +3,034 | 59.0K | +5% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | MELLETT PAUL J | CFO, Treas | F - Tax | $62.49 | -958 | 58.1K | -2% | -$59.9K | |
| 2022-02-15 | 2022-02-14 | ENTA | Adda Nathalie | SVP, Chief Medical Off | F - Tax | $62.49 | -954 | 35.0K | -3% | -$59.6K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | Adda Nathalie | SVP, Chief Medical Off | A - Grant | $0.00 | +3,034 | 35.9K | +9% | $0 |
| M | 2022-02-15 | 2022-02-14 | ENTA | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +3,034 | 340.2K | +0.9% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | Or Yat Sun | SVP, CSO | F - Tax | $62.49 | -953 | 339.2K | -0.3% | -$59.6K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | A - Grant | $0.00 | +1,616 | 8,416 | +24% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | F - Tax | $62.49 | -552 | 7,864 | -7% | -$34.5K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +3,034 | 47.2K | +7% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | Gardiner Nathaniel S. | SVP, GC | F - Tax | $62.49 | -957 | 46.2K | -2% | -$59.8K | |
| D | 2022-01-18 | 2022-01-15 | ENTA | Luly Jay R. | Pres, CEO, Dir | M - OptEx | $11.77 | +10.1K | 710.8K | +1% | +$118.4K |
| D | 2022-01-13 | 2022-01-11 | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.13 | -12.5K | 32.9K | -28% | -$879.1K |
| DM | 2022-01-13 | 2022-01-11 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $39.88 | +12.5K | 42.1K | +42% | +$499.9K |
| DM | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $86.35 | -13.5K | 32.9K | -29% | -$1.17M |
| DM | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $45.25 | +13.5K | 41.7K | +48% | +$611.9K |
| D | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | F - Tax | $87.68 | -842 | 32.9K | -2% | -$73.8K |
| 2021-12-03 | 2021-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $87.68 | -1,944 | 700.7K | -0.3% | -$170.4K | |
| 2021-12-03 | 2021-12-01 | ENTA | Gardiner Nathaniel S. | SVP, GC | F - Tax | $87.68 | -557 | 59.2K | -0.9% | -$48.8K | |
| 2021-12-03 | 2021-12-01 | ENTA | Or Yat Sun | SVP, CSO | F - Tax | $87.68 | -557 | 337.2K | -0.2% | -$48.8K | |
| 2021-12-03 | 2021-12-01 | ENTA | MELLETT PAUL J | CFO, Treas | F - Tax | $87.68 | -557 | 56.0K | -1.0% | -$48.8K | |
| D | 2021-11-23 | 2021-11-19 | ENTA | Adda Nathalie | SVP, Chief Medical Off | A - Grant | $0.00 | +6,800 | 33.7K | +25% | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | Luu Brendan | SVP, Business Dev | A - Grant | $0.00 | +6,800 | 6,800 | New | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | Kieffer Tara Lynn | SVP, New Product Dev | A - Grant | $0.00 | +6,800 | 6,800 | New | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +6,800 | 59.8K | +13% | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +25.7K | 702.7K | +4% | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | MELLETT PAUL J | CFO, Treas | A - Grant | $0.00 | +6,800 | 56.6K | +14% | $0 |
| D | 2021-11-23 | 2021-11-19 | ENTA | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +6,800 | 337.7K | +2% | $0 |
| DM | 2021-11-02 | 2021-11-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $84.89 | -9,547 | 26.9K | -26% | -$810.4K |
| D | 2021-11-02 | 2021-11-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $48.52 | +9,547 | 36.5K | +35% | +$463.2K |
| DM | 2021-10-13 | 2021-10-08+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $43.46 | +17.5K | 31.0K | +130% | +$760.5K |
| DM | 2021-10-13 | 2021-10-08+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.15 | -17.5K | 26.9K | -39% | -$1.23M |
| 2021-09-17 | 2021-09-15 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale | $59.06 | -4,516 | 677.0K | -0.7% | -$266.7K |
Purchase Sale Sale after option exercise All abbreviations